Future immunotherapies may leverage advancements in understanding mutations, T-cells targeting them, and genetic modification technologies like retroviruses.

“can we now take advantage of all this new biologic information about the role of mutations and te- cells that Target them about the ability to genetically modify cells in large numbers using retroviruses can we take advantage of that technology that biologic information to develop more effective immunotherapies in the uh uh in the years to come”